Signal2026-04-22
ClinicalTrials.gov

[PHASE1] Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Part of

Prostate Cancer Biomarker And Treatment Research

Open primary sourceSee the whole picture